当前位置: 首页 > 保健版 > 家庭健康 > 中年保健 > 中老年健康
编号:13303876
中老年少肌症与非酒精性脂肪肝的关联研究(5)
http://www.100md.com 2018年5月5日 《中国医学创新》 2018年第13期
     [12] Nahon P,Kettaneh A,Tengher-Barna I,et al.Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease[J].J Hepatol,2008,49(6):1062-1068.

    [13] Hashemi S A,Alavian S M,Gholami-Fesharaki M.Assessment of transient elastography(FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease:A systematic review and meta-analysis[J].Caspian J Intern Med,2016,7(4):242-252.

    [14] Studenski S A,Peters K W,Alley D E,et al.The FNIH sarcopenia project:rationale,study description,conference recommendations,and final estimates[J].J Gerontol A Biol Sci Med Sci,2014,69(5):547-558.

    [15] Cruzjentoft A J,Baeyens J P,Bauer J M,et al.Sarcopenia:European consensus on definition and diagnosis:Report of the European Working Group on Sarcopenia in Older People[J].Age Ageing,2010,39(4):412-423.

    [16] Dietrich P,Hellerbrand C.Non-alcoholic fatty liver disease,obesity and the metabolic syndrome[J].Best Pract Res Clin Gastroenterol,2014,28(4):637-653.

    [17] Koo B K,Kim D,Joo S K,et al.Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis[J].J Hepatol,2017,66(1):123-131.

    (收稿日期:2018-03-01) (本文編辑:董悦), 百拇医药(许雪娟 陈景娴 栾晓军 陈劲松)
上一页1 2 3 4 5


    参见:首页 > 保健版 > 家庭健康 > 中年保健 > 中老年健康